Cytoplasmic Viscosity is a Potential Biomarker for Metastatic Breast Cancer Cells - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Pré-Publication, Document De Travail Année : 2023

Cytoplasmic Viscosity is a Potential Biomarker for Metastatic Breast Cancer Cells

Résumé

Cellular microrheology has shown that cancer cells with high metastatic potential are softer compared to non-tumorigenic normal cells. These findings rely on measuring the apparent Young modulus of whole cells using primarily atomic force microscopy. This study aims to explore whether alternative mechanical parameters have discriminating features with regard to metastatic potential. Magnetic rotational spectroscopy (MRS) is employed in the examination of mammary epithelial cell lines: MCF-7 and MDA-MB-231, representing low and high metastatic potential, alongside normal-like MCF-10A cells. MRS utilizes active micron-sized magnetic wires in a rotating magnetic field to measure the viscosity and elastic modulus of the cytoplasm. All three cell lines display viscoelastic behavior, with cytoplasmic viscosities ranging from 10-70 Pa s and elastic moduli from 30-80 Pa. It is found that the tumorigenic MCF-7 and MDA-MB-231 cells are softer than the MCF-10A cells, with a twofold decrease in elastic modulus. To differentiate cells with low and high malignancy however, viscosity emerges as the more discriminating parameter, as MCF-7 exhibits a 5 times higher viscosity as compared to MDA-MB-231. These findings highlight the sensitivity of cytoplasmic viscosity to metastatic potential, suggesting its potential utility as a mechanical marker for malignant cancer cells.
Fichier principal
Vignette du fichier
MS Dessard et al. uploaded on BioRxiv 26-Oct-23.pdf (1.18 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04272840 , version 1 (06-11-2023)

Identifiants

Citer

Marie Dessard, Jean-Baptiste Manneville, Jean-François Berret. Cytoplasmic Viscosity is a Potential Biomarker for Metastatic Breast Cancer Cells. 2023. ⟨hal-04272840⟩
22 Consultations
10 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More